H1N1 update review

Saudi Medical Journal

Volumn 31, Issue 3, 2010, Pages 235-246

  Alenzi, Faris Q ^a  

^a PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE DERIVATIVE; AMANTADINE; INFLUENZA A H1N1 VACCINE; INFLUENZA VACCINE; OSELTAMIVIR; PNEUMOCOCCUS VACCINE; RIMANTADINE; UNCLASSIFIED DRUG; ZANAMIVIR;

CLINICAL FEATURE; HOSPITAL MANAGEMENT; HUMAN; IMMUNITY; INFECTION CONTROL; INFLUENZA; INFLUENZA A H1N1 INFECTION; INFLUENZA VIRUS A H1N1; PANDEMIC; REVIEW; SWINE INFLUENZA VIRUS; VACCINATION;

DISEASE OUTBREAKS; HEALTH OCCUPATIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 77949712510     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. World Health Organization. Influenza A (H1N1). (Updated 2009 December 23; Accessed 2009 October 4). Available from URL: http://www.who.int/csr/disease/ swineflu/en/index.html
2. Gallaher WR. Towards a sane and rational approach to management of Influenza H1N1 2009. Virol J 2009; 6: 51.
3. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000; 51: 407-421.
4. Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci 2001; 356: 1829-1839.
5. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989; 63: 4603-4608.
6. Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, et al. Influenza: emergence and control. J Virol 2004; 78: 8951-8959.
7. Easterday B. Swine influenza: historical perspectives. Proceedings of the 4th International Symposium on Emerging and Re-emerging Pig Diseases (Rome); 200 June 14-14; Parma, Italy. Italy: Department of Animal Health, Faculty of Veterinary Medicine, University of Parma 2003. p. 241-244
8. Shope R, Lewis P. Swine influenza: experimental transmission and pathology. J Exp Med 1931; 54: 349-359.
9. Smith W, Andrews CH, Laidlaw PP. A virus obtained from influenza patients. Lancet 1933; 225: 66-68.
10. Smith TF, Burgert EO Jr, Dowdle WR, Noble GR, Campbell RJ, Van Scoy RE. Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med 1976; 294: 708-710.
11. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 1998; 72: 7367-7373.
12. Scholtissek C, Hinshaw VS, Olsen CW. Influenza in pigs and their role as the intermediate host. In: Nicholson K, Webster RG, Hay AJ, editors. Textbook of influenza. 1st ed. Malden (MA): Blackwell Science; 1998. p. 137-145.
13. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152-179.
14. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007; 44: 1084-1088.
15. Zimmer SM, Burke DS. Historical perspective - Emergence of influenza A (H1N1) viruses. N Engl J Med 2009; 361: 279-285.
16. World Health Organization. Influenza A (H1N1). (Update 15 January 2010; Accessed 2009 October 4). Available from URL: www.emro.who.int/csr/h1n1/.
17. World Health Organization. Pandemic Influenza (H1N1) 2009. (2009 December 20, Accessed 2009 October 4). Available from URL: www.afro.who.int/ddc/ influenzaa/index.html.
18. World Health Organization. Regional Update. Pandemic (H1N1) 2009. (2010 January 14, Accessed 2009 October 4). Available from URL: www.new.paho.org/hq/ index.php?option=com-content&task=view&id=1866&Itemid=1167
19. World Health Organization. Pandemic (H1N1) 2009 - update 68. (Update 15 January 2010; Accessed 2009 October 5). Available from URL: www.who.int/csr/don/ 2009-10-02/en/index.html.
20. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008; 57: 1-60.
21. Pollock NR, Duong S, Cheng A, Han LL, Smole S, Kirby JE. Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing. Clin Infect Dis 2009; 49: e66-e68.
22. Leblanc JJ, Li Y, Bastien N, Forward KR, Davidson RJ, Hatchette TF. Switching gears for an influenza pandemic: validation of a duplex RT-PCR for simultaneous detection and confirmation of pandemic (H1N1) 2009. Journal of Clinical Microbiology 2009; 47; 3805-3813.
23. Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis 2009; 49: 1090-1093.
24. Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009; 45: 191-195.
25. Hurt AC, Baas C, Deng YM, Roberts S, Kelso A, Barr IG. Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses. Influenza Other Respi Viruses 2009; 3: 171-176.
26. Foo H KJ, Blyth CC, Iredell J, Dwyer DE. An evaluation of a rapid antigen test and two influenza PCRs during co-circulation of pandemic influenza A/H1N1 09 and seasonal influenza. Program and abstracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). 2009 September 12-15. San Francisco, California, USA. Washington, (DC): ASM Press; 2009.
27. Chan KH, Lam SY, Puthavathana P, Nguyen TD, Long HT, Pang CM et al. Comparative analytical sensitivities of six rapid influenza A antigen detection test kits for detection of influenza A subtypes H1N1, H3N2 and H5N1. J Clin Virol 2007; 38: 169-171.
28. Slepushkin AN, Obrosova-Serova NP, Schastny EI, Pugaeva VP, Chernetsov IuV. [Immune structure of the population of Moscow to the strains of the influenza viruses A(H3N2), A(H1N1) and B circulating in 1977]. Vopr Virusol 1979; 2: 175-180.
29. Mathur U, Bentley DW, Hall CB, Roth FK, Douglas RG Jr. Influenza A/Brazil/78(H1N1) infection in the elderly. Am Rev Respir Dis 1981; 123: 633-635.
30. Lee BW, Bey RF, Baarsch MJ, Emery DA. Subtype specific ELISA for the detection of antibodies against influenza A H1N1 and H3N2 in swine. J Virol Methods 1993; 45: 121-136.
31. Barbé F, Labarque G, Pensaert M, Van Reeth K. Performance of a commercial Swine influenza virus H1N1 and H3N2 antibody enzyme-linked immunosorbent assay in pigs experimentally infected with European influenza viruses. J Vet Diagn Invest 2009; 21: 88-96.
32. Rocha EP, Xu X, Hall HE, Allen JR, Regnery HL, Cox NJ. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol 1993; 74 (Pt 11): 2513-2518.
33. Cheng X, Li L, He J. [Characterization of HA1 genes of influenza A (H1N1) viruses isolated in Shenzhen City]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1999; 13: 340-344.
34. Cooper LA, Subbarao K. A simple restriction fragment length polymorphism-based strategy that can distinguish the internal genes of human H1N1, H3N2, and H5N1 influenza A viruses. J Clin Microbiol 2000; 38: 2579-2583.
35. Daum LT, Canas LC, Schadler CA, Ujimori VA, Huff WB, Barnes WJ, et al. A rapid, single-step multiplex reverse transcription-PCR assay for the detection of human H1N1, H3N2, and B influenza viruses. J Clin Virol 2002; 25: 345-350.
36. Al-Faress S, Cartet G, Ferraris O, Norder H, Valette M, Lina B. Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002. J Clin Virol 2005; 33: 230-236.
37. Maldonado J, Van Reeth K, Riera P, Sitja M, Saubi N, Espuna E, et al. Evidence of the concurrent circulation of H1N2, H1N1 and H3N2 influenza A viruses in densely populated pig areas in Spain. Vet J 2006; 172: 377-381.
38. Chutinimitkul S, Chieochansin T, Payungporn S, Samransamruajkit R, Hiranras T, Theamboonlers A, et al. Molecular characterization and phylogenetic analysis of H1N1 and H3N2 human influenza A viruses among infants and children in Thailand. Virus Res 2008; 132: 122-131.
39. Sinha NK, Roy A, Das B, Das S, Basak S. Evolutionary complexities of swine flu H1N1 gene sequences of 2009. Biochem Biophys Res Commun 2009; 390: 349-351.
40. Centers for Disease Control and Prevention (CDC). Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 453-458.
41. He J, Bose ME, Beck ET, Fan J, Tiwari S, Metallo J et al. Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2, and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2009 outbreak in Milwaukee, Wisconsin. J Clin Microbiol 2009; 47: 2772-2778.
42. Steain MC, Dwyer DE, Hurt AC, Kol C, Saksena NK, Cunningham AL, et al. Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification. Antiviral Res 2009; 84: 242-248.
43. Hawker J, Begg N, Blair I, Reintjes R, Weinberg J. Communicable disease control handbook. United Kingdom: Blackwell Science; 2005 p. 241-286
44. Webber R. Communicable disease epidemiology and control. United Kingdom: CABI Publishing; 2005. p. 166-180
45. Wicker S, Rabenau HF, Gottschalk R. Influenza pandemic: Would healthcare workers come to work? An analysis of the ability and willingness to report to duty. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009; 52: 862-869.
46. Radonovich LJ Jr, Perl TM, Davey V, Cohen H. Preventing the soldiers of health care from becoming victims on the pandemic battlefield: respirators or surgical masks as the armor of choice. Disaster Med Public Health Prep 2009; 3 Suppl 2: S203-S210.
47. Centers for Disease Control and Prevention. H1N1 Flu (Swine Flu). (15 January 2010; Accessed 2009 October 5). Available from URL: [http://www.cdc.gov/ swineflu]
48. Lessler J, Cummings DA, Fishman S, Vora A, Burke DS. Transmissibility of swine flu at Fort Dix, 1976. J R Soc Interface 2007; 4: 755-762.
49. Tenpenny S. The Truth About the Flu Shot. (2009 November 28; Accessed 2009 October 5. Available from URL: [http:// drtenpenny.com/the-truth-about-the- flu-Shot.aspx]
50. Centers for Disease Control and Prevention. H1N1 Flu (Swine Flu) (Update 2010 January 15; Accessed 2009 October 5) Available from URL: http://www.cdc.gov/H1N1FLU/
51. Centers for Disease Control and Prevention. Influenza: The Disease. (Update 2009 October 14; Accessed 2009 October 4). Available from URL: http://www.cdc.gov/flu/about/disease/index.htm
52. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361: 2424-2435.
53. De Groot AS, Ardito M, McClaine EM, Moise L, Martin WD. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 2009; 27: 5740-5747.
54. Cohen J. Swine flu outbreak. Past pandemics provide mixed clues to H1N1's next moves. Science 2009; 324: 996-997.
55. Michaelis M, Doerr HW, Cinatl J Jr. An Influenza A H1N1 Virus Revival - Pandemic H1N1/09 Virus. Infection 2009; 18. [Epub ahead of print]
56. Butler D. Swine flu goes global. Nature 2009; 458: 1082-1083
57. Sylte MJ, Suarez DL. Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol 2009; 333: 227-224.
58. Centers for Disease Control and Prevention (CDC). Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 2009; 58: 521-524.
59. Dawood FS, Jain S. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605-2615.
60. Centers for Disease Control and Prevention. Update: drug susceptibility of swine origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 433-435.
61. Centers for Disease Control and Prevention. Pregnant Women and Novel Influenza A (H1N1) Virus: Considerations for Clinicians (Update 2009 June 30; Accessed 2009 September 30). Available from URL: http://www.cdc.gov/H1N1flu/ clinician-pregnant.htm
62. Centers for Disease Control and Prevention. What Should Pregnant Women Know About 2009 H1N1 Flu (Swine Flu)? (Update 2009 October 19, Accessed 2009 September 30). Available from URL: http://www.cdc.gov/h1n1flu/guidance/pregnant. htm
63. Centers for Disease Control and Prevention. Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel (Update 2009 October 14, Accessed 2009 September 30). Available from URL: http://www.cdc.gov/h1n1flu/guidelines- infection-control.htm
64. Tanaka T, Nakajima K, Murashima A, Garcia-Bournissen F, Koren G, Ito S. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women (review). CMAJ 2009; 18: 55-58.
65. Centers for Disease Control and Prevention. Interim guidance for use of 23-valent pneumococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak (Update 2009 October 26, Accessed 2009 September 2009). Available from URL: http://www.cdc.gov/h1n1flu/guidance/ppsv-h1n1.htm